metricas
covid
Annals of Hepatology ATORVASTATIN AND RIFAXIMIN IN THYROID PREVENT LIVER THYROID METABOLISM ABNORMALI...
Journal Information

Statistics

Follow this link to access the full text of the article

#118
ATORVASTATIN AND RIFAXIMIN IN THYROID PREVENT LIVER THYROID METABOLISM ABNORMALITIES IN HEPATOCELLULAR CARCINOMA: IN VITRO AND IN VIVO STUDY
Bruno de Souza Basso1, Thaliane Carvalho de Oliveira1, Rachel Pinto Dornelles1, Daiane Dias Cabeleira1, Elisa Carolina Lange1, Cristiane Gisele Gomes1, Emanuela Tureta Cagnini1, Luca Prá Scherer1, Henrique Mombach Barreto1, Leonardo Priesnitz Friedrich1, Gustavo Santos Lucca1, Maria Alice Smielevski Gomes1, Carolina Fischer Nadvorny1, Jessica Sindo1, Maria Ines Gonzales Solari1, Patricia Bencke Grudzinski1, Laura Alvarez2, Ezequiel Ridruejo3, Simone Macagnin Wajner1, Mario Reis Alvares-da-Silva1
1 Federal do Rio Grande do Sul. PO, Porto Alegre. Brasil
2 Universidad de Buenos Aires. Buenos Aires. Argentina.
3 CEMIC. Buenos Aires. Argentina.
Read
155
Times
was read the article
56
Total PDF
99
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 8 9 17
2025 11 42 25 67
2025 10 44 18 62
2025 9 5 4 9

Follow this link to access the full text of the article